Compare GRDN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDN | LMAT |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2023 | 2006 |
| Metric | GRDN | LMAT |
|---|---|---|
| Price | $37.41 | $80.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $40.60 | ★ $105.80 |
| AVG Volume (30 Days) | 337.7K | ★ 403.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | ★ $1,448,685,000.00 | $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $7.63 | $8.88 |
| P/E Ratio | $117.77 | ★ $56.10 |
| Revenue Growth | ★ 17.93 | 13.53 |
| 52 Week Low | $23.18 | $78.27 |
| 52 Week High | $47.02 | $118.01 |
| Indicator | GRDN | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 39.73 | 34.28 |
| Support Level | $35.56 | $79.02 |
| Resistance Level | $38.12 | $88.35 |
| Average True Range (ATR) | 1.33 | 1.94 |
| MACD | -0.14 | 0.06 |
| Stochastic Oscillator | 8.21 | 19.57 |
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.